Medical Xpress - Cardiology

FEBRUARY 25, 2025

Researchers at the TechMed Center of the University of Twente and Radboud University Medical Center have removed blood clots with wireless magnetic robots. This innovation promises to transform treatment for life-threatening vascular conditions like thrombosis.

Blood Clot 108

Blood Clot Thrombosis Innovation Research 108

Frontiers in Cardiovascular Medicine

JANUARY 30, 2025

However, innovation in MHV design faces several challenges: strict performance and biocompatibility requirements, limited understanding of the mechanisms underlying MHV thrombosis, and a lack of effective testing methodologies to assess how design variations impact both hemodynamic performance and thrombogenicity of MHVs.

Heart Valves 52

Heart Valves Aortic Aortic valve Blood Clot 52

DAIC

MARCH 24, 2025

The catheter is designed to elevate care for patients with venous thrombosis, a serious condition caused by a blood clot forming in the veins of the legs or abdomen that can have a life-threatening impact if left untreated. Food and Drug Administration (FDA) 510(k) clearance of the 82 cm version of its Symphony 16F catheter.

Blood Clot 52

Blood Clot Vascular Care Technology Thrombosis 52

DAIC

JUNE 12, 2024

Impacting 25 million people globally [1], deep venous disease results from venous thromboembolism, a condition that occurs when a blood clot forms in the vein [2]. Current and future burden of venous thrombosis: Not simply predictable. It is the third most common cardiovascular disease [2]. J Thromb Haemost 2014; 12: 1580–90.

Stent 105

Stent Stents Anatomy Ultrasound 105

DAIC

MARCH 8, 2024

As an alternative therapeutic option, LVAD heart pumps have been implanted to help patients with end-stage heart failure sustain blood circulation in the body. However, there are shortcomings associated with LVAD implantation: complications include infection, blood clotting (thrombosis), stroke and bleeding.

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98